Workflow
复星医药: 复星医药公司债券募集资金管理制度(2025年修订)
Zheng Quan Zhi Xing·2025-07-15 09:29

Core Points - The document outlines the management and usage of funds raised through bond issuance by Shanghai Fosun Pharmaceutical (Group) Co., Ltd, ensuring compliance with relevant laws and regulations [1][8] - The company is required to establish a special account for the storage of raised funds, which must be used solely for the intended purposes and managed according to strict internal procedures [2][3][4] - The use of raised funds is primarily restricted to the company's main business activities, with specific prohibitions against financial investments and unauthorized changes in fund usage [5][6][7] Fund Management and Usage - The company must follow internal approval processes for all expenditures related to investment projects funded by raised capital, ensuring transparency and accountability [4][6] - Any changes to the intended use of raised funds must be approved by the board or authorized personnel, with necessary disclosures made to stakeholders [7][8] - The financial department is responsible for maintaining detailed records of fund usage and must report any irregularities to the trustee [15][16]